Clinical Data Management and Pharmacovigilance Training for Medical Device Teams
Why clinical data management and pharmacovigilance are taught together for device and combination product teams, and what each should cover.

Clinical data management (CDM) and pharmacovigilance (PV) are usually taught as pharma skills, but device and combination product companies need both: clean clinical study data to support a submission, and a working vigilance process once the product is on the market. This guide explains what training in these two areas should cover for medical device teams and why they are often taught together.
Who this is for
- Clinical research associates and data managers moving from pharma into medical device or combination product studies.
- Quality and regulatory staff who own post-market vigilance and need to understand data handling upstream of it.
- Graduates building a career in clinical research who want device-sector skills alongside pharma fundamentals.
Why these two are taught together
Clinical data management produces the dataset a device submission relies on; post-market vigilance is what happens to that same product once real-world use begins generating complaints and adverse events. Training them together gives you the full lifecycle view: how data is collected and controlled during a study, and how similar discipline carries into post-market reporting once a device is approved. See post-market surveillance for medical devices for how the post-market side works under EU MDR and FDA.
What clinical data management training should cover
1. The CDM lifecycle
Study set-up, case report form design, data entry and query management, through database lock.
2. Data standards and quality
How data standards apply to device studies, and how data quality is checked before it supports a submission claim.
3. Device-specific study design
How IDE and significant-risk device studies differ from typical pharma trial structures. See FDA IDE and device clinical studies.
What pharmacovigilance and vigilance training should cover
1. Reportability assessment
How to decide whether an event must be reported, and to which authority, under FDA and EU MDR vigilance rules.
2. Signal and trend detection
How complaint and adverse event trends feed back into risk management and labelling decisions. See CAPA and complaint handling.
3. PSUR and periodic reporting
What a periodic safety update report contains under EU MDR, and how it differs from a one-off adverse event report.
Why US demand for this combination is growing
Combination products and connected devices that generate their own usage and safety data are a growing part of the US market, and companies building these products need staff who understand both clinical data handling and post-market safety reporting, rather than treating them as two unconnected specialisms. Clinical research outsourcing also continues to expand, which is widening the pool of CDM and PV roles open to candidates with device-sector training.
How to choose a programme
- Does it cover device-specific context, such as IDE studies and EU MDR vigilance, not only pharma trial and drug safety basics?
- Does it connect data management to what happens downstream in post-market surveillance?
- Is there a practical exercise, such as a mock reportability assessment or a data query scenario?
Where AptSkill can help
Our Clinical Data Management Course, Pharmacovigilance Course and combined CDM and Pharmacovigilance Course are built for people entering or growing a career across both areas, with device-specific context most generic CDM or PV training leaves out.
Frequently asked questions
Do I need a clinical background to train in CDM or pharmacovigilance?
Not necessarily. Many entrants come from life sciences, nursing or data-focused backgrounds and build clinical and regulatory context during training.
Is pharmacovigilance only relevant to drugs, not devices?
No. Devices and combination products have their own post-market vigilance obligations under FDA and EU MDR, even though the term “pharmacovigilance” originated with medicines.
Which should I learn first, CDM or pharmacovigilance?
It depends on the role you are targeting. If you are unsure, a combined course gives you both and lets you specialise once you see which work you prefer.
Talk to the AptSkill team
Tell us which area you want to focus on and your background, and we will point you to the right course.
Ask about CDM and pharmacovigilance training
Ready to take the next step?
Questions? Email aptskill6@gmail.com and the AptSkill team will respond promptly.